Download presentation
Presentation is loading. Please wait.
1
SIRT6 Puts Cancer Metabolism in the Driver’s Seat
Costas A. Lyssiotis, Lewis C. Cantley Cell Volume 151, Issue 6, Pages (December 2012) DOI: /j.cell Copyright © 2012 Elsevier Inc. Terms and Conditions
2
Figure 1 Loss of SIRT6-Mediated Suppression of Cancer Metabolism Promotes Tumorigenesis (A) The deacetylase SIRT6 acts as a corepressor of HIF-1α- and MYC-dependent cancer metabolism but does not globally repress HIF-1α or MYC transcription. (B) SIRT6 inhibits aerobic glycolysis, anabolic glutamine metabolism, and ribosome biogenesis. Together, activation of these metabolic pathways promotes tumorigenesis and tumor growth. Inhibition of aerobic glycolysis by knockdown of PDK1 using short hairpin RNA (shPDK1) or pharmacological inhibition with dichloroacetate (DCA) blocks the tumorigenic activity of SIRT6 loss. Cell , DOI: ( /j.cell ) Copyright © 2012 Elsevier Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.